| http://www.w3.org/ns/prov#value | - The supplemental therapeutic compositions can be administered before, concurrently or after administration of the anti-CD20 antibodies.As discussed supra, the antibodies of the present invention can be used for treating B cell lymphoma and leukemia, and other B cell diseases or disorders.
|
